°í·Á´ëÇб³¾È¾Ïº´¿ø Myocardial Ischemia Symposium In Korea 2019 : 2019-03-08±³À°ÀÏÀÚ : 2019-03-08
±³À°Àå¼Ò : Millennium Seoul Hilton(Grand Ballroom A, B, Junior Ballroom A, B, C)
±³À°ÁÖÁ¦ :
Myocardial Ischemia Symposium In Korea 2019ÁÖÃÖ±â°ü : °í·Á´ëÇб³¾È¾Ïº´¿ø
´ã´çÀÚ : ¹èÁø¼º
¿¬¶ôó : 02-920-6715
À̸ÞÀÏ :
mwvagabond@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 550¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 16 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:00~08:20 A Fib and Stroke (or Stroke Prevention in A Fib) ÀÓÈ«ÀÇ(°í´ë±¸·Îº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:20~08:40 PFO Closure for Prevention of Stroke Á¶À±Çü(¸íÁöº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:40~09:00 Asymptomatic Carotid Stenosis, When to Treat? ¹®ÁÖ¼±(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:00~08:20 New Anti-diabetic Agents ; Saving Life? Á¤Àΰæ(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:20~08:40 LDL Cholesterol, The Lower is The Better ±è³²ÈÆ(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:40~09:00 Blood Thinning Medication is Essential to Reduce CV Death Á¤¿µÈÆ(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:00~08:20 Dont Ignore Missing Values: Missing Value Imputation ¾ÈÇüÁø(°í·Á´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:20~08:40 Things to Know about Meta-analysis ÀÌÁØ¿µ(°í·Á´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:40~09:00 New Statistical Approach: Causal Medication Analysis À̵¿ÈÆ(°í·Á´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:05~09:20 What Are The New Devices and Their Outcomes in Renal Denervation? ±èº´±Ø(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:20~09:40 What Are Carotid Neuromodulation and Arterio-venous Fistula Creation in Hypertension Control ¹ÚÀçÇü(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:40~10:00 Novel Medications in The Treatment of Hypertension ¼ÕÀϼ®(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 10:00~10:20 What Are The Suggested Mechanisms of Resistant Hypertension and Its Management ÀÓ»óÇö(ºÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 10:35~11:00 Recent Update in IVUS-guided vs Angiography-guided PCI in ACS Bill D. Gogas(Nanjing First Hospital, China)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:00~11:20 What is The Role of NIRS in ACS Á¤ÇÑ»ù(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:20~11:45 Cardiac CT Focused on CTO or Calcification Masaaki Okutsu(New Tokyo Hospital, Japan)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:45~12:00 How The Pre-procedural Coronary CT Imaging Changed My Practice ÃÖÁøÈ£(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:00~12:20 Cardiogenic Shock - Complex Clinical Interplay ¾Èö¹Î(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:20~12:40 Tips to Reduce ECMO Duration and ICU Stay ÀÓÁÖ¿µ(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:40~13:00 Predicting and Treating Sudden Death Samuel Calvert Dudley(University of Minnesota, USA)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:00~13:15 Which Patients Can Benefit from CTO Revascularization: Criteria for Selecting Patients for CTO PCI ±¹Çüµ·(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:15~13:30 What Are The New Devices in CTO PCI and How Can We Use Them? À±ÇõÁØ(°è¸í´ëµ¿»êÀÇ·á¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:30~13:45 Role of Intracoronary Imaging in CTO Intervention À̽Âȯ(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:45~14:00 Selecting Patient Criteria for Antegrade vs. Retrograde CTO PCI ¹Ú»óÈ£(¼øõÇâ´ëõ¾Èº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:00~14:15 What is Important Anatomy in Echocardiography to Close a PFO and LAA? È«±×·ç(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:15~14:35 How Can We Use a CT for PFO and LAA in Clinical Practice? Á¶Àͼº(Á߾Ӵ뺴¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:35~14:55 Close a PFO: Who is an Appropriate Candidate and What is a Cirital Issue? Teiji Akagi(Okayama University Hospital, Japan)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:55~15:15 Close a LAAO: Who is an Appropriate Candidate and What is a Critical Issue? Simon Lam(University of Hong Kong, Hong Kong)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 15:30~15:50 Imaging Guidance during Aortic Valve Intervention: Do We Need it? È«±×·ç(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 15:50~16:15 TAVI for Bicuspid Aortic Valve Ariel Finklestein(Tel Aviv Medical Center, Israe)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 16:15~16:40 Durability of TAVI Valves Jian Ye(University of British Columbia, Canada)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 16:40~17:00 Clinical Evidences for Sutureless Aortic Valves À̽ÂÇö(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:05~09:20 Mobile Application for Cardiac Rehabilitation ±èÀÀÁÖ(°í´ë±¸·Îº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:20~09:40 Advancing 12-lead ECG-based Care System in Emergency Settings Â÷¿øö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:40~10:00 Surveillence of Adverse Drug Reaction by Using Electronic Health Records À̼öÇö(°Ç¾ç´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 10:00~10:20 AI Application in Cardiovascular Imaging ¾çµ¿Çö(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 10:35~11:00 The Future of Myocardial Injury Biomarkers in Cardiovascular Disease Michael Marbe(The Rayne Institute, UK)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:00~11:25 Protease-Cathepsins as Biomaker and/or Biomarker in Vascular Aging and Cardiovascular Disease Xian Wu Cheng(Nagoya University Graduate School of Medicine, Japan)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:25~11:40 Discovery of Novel Biomarkers: Recent Proteomics ÀÌÁöÀº(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:40~12:00 Microfluidic Platform technology for diagnostic immunoassay Á¤¼®(°í·Á´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:00~12:20 Controversies in Statin and Vascular Calcification - Can We Neglect? ±è»ó¹Î(ÃæºÏ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:20~12:40 How about Initial Ezetimibe Combination? ¿øÈ£¿¬(Á߾Ӵ뺴¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:40~13:00 Potential Implications of PCSK9 Inhibitors for Korean Patients? ÀÌ»óÇÐ(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:00~13:20 Incidence of Stent Failure, Periodical Changes from BMS to 2nd Generation DES ±è¼öÁß(°æÈñ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:20~13:40 IVUS is Essential to Evaluate The Cause of Stent Failure ±è»ó¹Î(ÃâºÏ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:40~14:00 How to Use FFR in The Patients with Instent Restenosis µµÁØÇü(ÀÎÁ¦´ëÀÏ»ê¹éº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:00~14:20 How to Treat: Left Main ISR with/without Bifurcation ¾ÈÁ¤¹Î(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:20~14:40 What You Need to Know for ISR CTO Intervention ÀÌÀåÈÆ(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:40~15:00 How to Deal The Patient with Long ISR Lesion ½ÅÀº¼®(¿ï»êº´¿ø)